cilofexor (GS-9674) / Gilead  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cilofexor (GS-9674) / Gilead
PRIMIS, NCT03890120 / 2019-000204-14: Study of Cilofexor in Adults With Primary Sclerosing Cholangitis

Terminated
3
419
Europe, Canada, Japan, US, RoW
Cilofexor, GS-9674, Placebo
Gilead Sciences
Primary Sclerosing Cholangitis
11/22
12/22

Download Options